Predicting effectiveness of anti-VEGF injection through self-supervised learning in OCT images
-
Published:2022
Issue:2
Volume:20
Page:2439-2458
-
ISSN:1551-0018
-
Container-title:Mathematical Biosciences and Engineering
-
language:
-
Short-container-title:MBE
Author:
Feng Dehua1, Chen Xi1, Wang Xiaoyu1, Mou Xuanqin1, Bai Ling2, Zhang Shu3, Zhou Zhiguo4
Affiliation:
1. School of Information and Communications Engineering, Xi'an Jiaotong University, Shaanxi 710049, China 2. Department of Ophthalmology, the Second Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710004, China 3. Department of Geriatric Surgery, the Second Affiliated Hospital of Xi'an Jiaotong University, Shaanxi 710004, China 4. Department of Biostatistics and Data Science, University of Kansas Medical Center, KS 66160, USA
Abstract
<abstract>
<p>Anti-vascular endothelial growth factor (Anti-VEGF) therapy has become a standard way for choroidal neovascularization (CNV) and cystoid macular edema (CME) treatment. However, anti-VEGF injection is a long-term therapy with expensive cost and may be not effective for some patients. Therefore, predicting the effectiveness of anti-VEGF injection before the therapy is necessary. In this study, a new optical coherence tomography (OCT) images based self-supervised learning (OCT-SSL) model for predicting the effectiveness of anti-VEGF injection is developed. In OCT-SSL, we pre-train a deep encoder-decoder network through self-supervised learning to learn the general features using a public OCT image dataset. Then, model fine-tuning is performed on our own OCT dataset to learn the discriminative features to predict the effectiveness of anti-VEGF. Finally, classifier trained by the features from fine-tuned encoder as a feature extractor is built to predict the response. Experimental results on our private OCT dataset demonstrated that the proposed OCT-SSL can achieve an average accuracy, area under the curve (AUC), sensitivity and specificity of 0.93, 0.98, 0.94 and 0.91, respectively. Meanwhile, it is found that not only the lesion region but also the normal region in OCT image is related to the effectiveness of anti-VEGF.</p>
</abstract>
Publisher
American Institute of Mathematical Sciences (AIMS)
Subject
Applied Mathematics,Computational Mathematics,General Agricultural and Biological Sciences,Modeling and Simulation,General Medicine
Reference56 articles.
1. W. L. Wong, X. Su, X. Li, C. M. G. Cheung, R. Klein, C. Y. Cheng, et al., Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: A systematic review and meta-analysis, Lancet Glob. Health, 2 (2014), e106–e116, https://doi.org/10.1016/S2214-109X(13)70145-1. 2. H. E. Grossniklaus, W. Green, Choroidal neovascularization, Am. J. Ophthalmol., 137 (2004), 496–503. https://doi.org/10.1016/j.ajo.2003.09.042 3. M. R. Hee, C. R. Baumal, C. A. Puliafito, J. S. Duker, E. Reichel, J. R. Wilkins, et al., Optical coherence tomography of age-related macular degeneration and choroidal neovascularization, Ophthalmology, 103 (1996), 1260–1270. https://doi.org/10.1016/S0161-6420(96)30512-5 4. T. D. Ting, M. Oh, T. A. Cox, C. H. Meyer, C. A. Toth, Decreased visual acuity associated with cystoid macular mdema in meovascular age-related macular degeneration, Arch. Ophthalmol., 120 (2002), 731–737. https://doi.org/10.1001/archopht.120.6.731 5. N. Shah, M. G. Maguire, D. F. Martin, J. Shaffer, G. S. Ying, J. E. Grunwald, et al., Angiographic cystoid macular edema and outcomes in the comparison of age-related macular degeneration treatments trials, Ophthalmology, 123 (2016), 858–864. https://doi.org/10.1016/j.ophtha.2015.11.030
|
|